Alaunos Therapeutics (TCRT) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Michael Wong resigned as Vice President, Finance of Alaunos Therapeutics, and Ferdinand Groenewald has been appointed in his stead through a consulting agreement effective immediately. Groenewald, a seasoned finance professional and CPA with extensive experience in various financial roles, will lead the company’s accounting and financial reporting for $15,000 per month plus expenses. His term is indefinite, with a 30-day termination notice by either party, and includes customary officer indemnification provisions. Groenewald’s prior roles include leadership positions at Muscle Maker, Inc., and board memberships at several Nasdaq-listed companies.
For further insights into TCRT stock, check out TipRanks’ Stock Analysis page.
